Oracle (NYSE:ORCL) Shares Up 2.8% – Still a Buy?

Oracle Corporation (NYSE:ORCL) shot up 2.8% during trading on Tuesday . The stock traded as high as $186.52 and last traded at $185.4230. 23,102,514 shares traded hands during mid-day trading, a decline of 18% from the average session volume of 28,259,928 shares. The stock had previously closed at $180.29.

Key Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Wedbush reiterated an Outperform rating and $225 price target, calling recent pullbacks “noise” and affirming confidence in Oracle’s AI/cloud growth trajectory. Wedbush Brushes Off AI Concerns, Sticks With Oracle Corporation (ORCL)
• Positive Sentiment: Reports that Oracle secured a classified U.S. Defense Department AI deal boosted investor optimism about high‑margin, strategic AI revenue streams and credibility as a government AI supplier. Oracle secures classified AI deal with US Defense Department
• Positive Sentiment: Bloomberg/Yahoo reporting that financing for Oracle’s $16B Michigan data‑center campus closed (Bank of America anchored a large bond sale) supports the company’s hyperscaler ambitions and long‑term AI capacity expansion. Oracle (ORCL) Secures Financing for Data Center in Michigan
• Positive Sentiment: Construction partner Walbridge began work on what’s described as the largest project in its history — the Related Digital campus being built exclusively for Oracle and OpenAI — underscoring tangible progress on capacity that underpins future AI cloud revenue. Walbridge Is Building the Largest Project in Its 110-Year History — Right Here in Michigan
• Neutral Sentiment: Oracle’s Project Jupiter (a shift to on‑site fuel cells with Bloom Energy) highlights efforts to manage AI power costs and ESG optics; this can lower operating risk long‑term but raises near‑term capital and execution focus. Oracle Project Jupiter Puts AI Power Costs And Valuation In Focus
• Neutral Sentiment: Oracle announced a health‑research partnership (Africa Clinical Research Network) using its safety and analytics tools — positive for reputation and product diversification but unlikely to move near‑term revenue materially. Oracle Supports Africa Clinical Research Network (ACRN) to Advance a New Era of Clinical Research, Launches First Trial
• Negative Sentiment: Ongoing concerns about OpenAI missing targets have weighed on Oracle sentiment because OpenAI is a large, high‑visibility AI customer; market worry about its demand trajectory has pressured ORCL previously. What Oracle Investors Need to Know About OpenAI’s Struggles
• Negative Sentiment: Analyst pieces and investor notes flag AI spending, heavy capital deployment and higher leverage as execution and cash‑flow risks — these remain key negatives investors are watching as Oracle accelerates capex and debt for hyperscaler ambitions. Oracle Corporation (ORCL) Slides on AI Spending Concerns – Is This a Buying Opportunity?

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on ORCL shares. Monness Crespi & Hardt restated a “hold” rating on shares of Oracle in a research report on Wednesday, March 11th. BMO Capital Markets cut their price target on shares of Oracle from $205.00 to $200.00 and set an “outperform” rating for the company in a report on Wednesday, March 11th. Melius Research set a $160.00 price target on shares of Oracle in a research report on Monday, February 9th. UBS Group reaffirmed a “buy” rating on shares of Oracle in a report on Monday, February 2nd. Finally, Stephens reaffirmed an “equal weight” rating and issued a $254.00 price target on shares of Oracle in a report on Tuesday, April 7th. Three research analysts have rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $259.56.

Oracle Stock Performance

The company’s 50-day moving average price is $154.96 and its two-hundred day moving average price is $188.20. The company has a debt-to-equity ratio of 3.66, a quick ratio of 1.35 and a current ratio of 1.35. The stock has a market cap of $533.29 billion, a PE ratio of 33.29, a PEG ratio of 1.64 and a beta of 1.55.

Oracle (NYSE:ORCL) last posted its quarterly earnings data on Tuesday, March 10th. The enterprise software provider reported $1.79 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.08. The firm had revenue of $17.19 billion for the quarter, compared to analysts’ expectations of $16.91 billion. Oracle had a net margin of 25.30% and a return on equity of 62.70%. The business’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter last year, the company posted $1.47 EPS. Oracle has set its Q4 2026 guidance at 1.960-2.000 EPS. On average, equities research analysts forecast that Oracle Corporation will post 6.08 EPS for the current year.

Oracle Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 24th. Stockholders of record on Thursday, April 9th were given a dividend of $0.50 per share. The ex-dividend date was Thursday, April 9th. This represents a $2.00 annualized dividend and a dividend yield of 1.1%. Oracle’s dividend payout ratio (DPR) is 35.91%.

Insider Buying and Selling at Oracle

In related news, EVP Stuart Levey sold 15,000 shares of the stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $176.19, for a total transaction of $2,642,850.00. Following the transaction, the executive vice president owned 3,429 shares of the company’s stock, valued at approximately $604,155.51. This trade represents a 81.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Clayton M. Magouyrk sold 10,000 shares of the stock in a transaction on Monday, February 9th. The shares were sold at an average price of $155.23, for a total transaction of $1,552,300.00. Following the transaction, the chief executive officer directly owned 134,030 shares in the company, valued at approximately $20,805,476.90. This represents a 6.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 40.90% of the company’s stock.

Hedge Funds Weigh In On Oracle

Several institutional investors and hedge funds have recently made changes to their positions in the business. Mine & Arao Wealth Creation & Management LLC. boosted its holdings in Oracle by 0.7% during the 3rd quarter. Mine & Arao Wealth Creation & Management LLC. now owns 5,281 shares of the enterprise software provider’s stock valued at $1,485,000 after acquiring an additional 36 shares during the period. Avion Wealth boosted its holdings in Oracle by 16.6% during the 3rd quarter. Avion Wealth now owns 260 shares of the enterprise software provider’s stock valued at $73,000 after acquiring an additional 37 shares during the period. Keystone Wealth Services LLC boosted its holdings in Oracle by 2.0% during the 3rd quarter. Keystone Wealth Services LLC now owns 2,044 shares of the enterprise software provider’s stock valued at $575,000 after acquiring an additional 40 shares during the period. Allen Capital Group LLC boosted its holdings in Oracle by 1.3% during the 3rd quarter. Allen Capital Group LLC now owns 3,276 shares of the enterprise software provider’s stock valued at $921,000 after acquiring an additional 41 shares during the period. Finally, Noesis Capital Mangement Corp boosted its holdings in Oracle by 1.3% during the 3rd quarter. Noesis Capital Mangement Corp now owns 3,377 shares of the enterprise software provider’s stock valued at $950,000 after acquiring an additional 42 shares during the period. Institutional investors own 42.44% of the company’s stock.

About Oracle

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.